Serum biomarker that reflects use, dose of metformin identified

December 21, 2016

(HealthDay)—The growth differentiation factor 15 (GDF15) is a novel biomarker for the use and dosing of metformin, according to a study published online Dec. 14 in Diabetes Care.

Hertzel C. Gerstein, M.D., from McMaster University in Hamilton, Canada, and colleagues assessed 237 serum biomarkers from participants in the Outcome Reduction with Initial Glargine Intervention trial to identify markers associated with metformin dosing or use. Of the 8,401 , 2,317 were taking metformin.

The researchers found that GDF15 was strongly linked to metformin. For every one standard deviation increase in GDF15 level, the odds of metformin use varied from 3.73 to 3.94, depending on other variables included in the analysis. The odds ranged from 0.71 to 1.24 for the remaining 25 linked biomarkers. A 1.64 ng/mL higher GDF15 level predicted a 188-mg higher metformin dose (P < 0.0001).

"GDF15 levels are a biomarker for the use of metformin in people with dysglycemia, and its concentration reflects the dose of ," the authors write.

Several authors disclosed financial ties to pharmaceutical companies, including Sanofi, which funded the study.

Explore further: Metformin alters gut microbiota composition in diabetes (Update)

More information: Full Text (subscription or payment may be required)

Related Stories

Metformin alters gut microbiota composition in diabetes (Update)

November 19, 2016
(HealthDay)—Metformin seems to alter gut microbiota composition, according to a study published online Nov. 14 in Diabetes Care.

Greater drop in hemoglobin A1c with empagliflozin plus metformin

August 16, 2016
(HealthDay)—Twenty-four weeks of empagliflozin + metformin correlates with a significantly greater reduction in hemoglobin A1c (HbA1c) compared with once-daily empagliflozin or twice-daily metformin, according to a study ...

Metformin linked to increased risk of acute dialysis in T2DM

August 23, 2016
(HealthDay)—For patients with type 2 diabetes, metformin is associated with about a 50 percent increase in the risk of acute dialysis compared to sulfonylureas, according to a study published online Aug. 18 in Diabetes, ...

High-dose metformin linked to increases in child height

October 22, 2015
(HealthDay)—Metformin use at high doses seems to be associated with increases in height among children, according to a review published online Sept. 28 in JAMA Pediatrics.

Metformin use associated with less CRC risk in US population

April 1, 2015
(HealthDay)—For patients with diabetes in the United States, metformin use is associated with reduced risk of developing colorectal cancer (CRC), according to a study published in the April 1 issue of Cancer.

Metformin, sitagliptin prolong normoglycemia remission in DKA

September 2, 2016
(HealthDay)—For patients with new-onset diabetic ketoacidosis (DKA) and severe hyperglycemia, metformin and sitagliptin treatment after normoglycemia remission correlate with increased relapse-free survival and prolonged ...

Recommended for you

Genetic discovery may help better identify children at risk for type 1 diabetes

January 17, 2018
Six novel chromosomal regions identified by scientists leading a large, prospective study of children at risk for type 1 diabetes will enable the discovery of more genes that cause the disease and more targets for treating ...

Women who have gestational diabetes in pregnancy are at higher risk of future health issues

January 16, 2018
Women who have gestational diabetes mellitus (GDM) during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future, according to new research led by the ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

Big strides made in diabetes care

January 5, 2018
(HealthDay)—This past year was a busy, productive one for diabetes research and care.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.